TickerFactsScreenerDevelopers

Niagen Bioscience, Inc. (NAGE) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2019: $18.81M2020: $16.70M2021: $28.22M2022: $20.30M2023: $27.20M2024: $44.50M$44.50M
2019Cash & Equivalents (USD)2024
Fiscal YearCash & EquivalentsChange YoY
2024$44.50M+63.6%
2023$27.20M+34.0%
2022$20.30M-28.1%
2021$28.22M+69.0%
2020$16.70M-11.2%
2019$18.81M—